MP
XAGE

Mangrove Partners’s Longevity Health Holdings, Inc. Common Stock XAGE Stock Holding History

Mangrove Partners’s Portfolio XAGE Stock Details XAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,544
Closed -$1.05M – 280
2022
Q4 		$1.05M Sell
3,544
-3,681
-51% -$1.09M 0.06% 241
2022
Q3 		$2.11M Buy
7,225
+5,790
+403% +$1.69M 0.12% 222
2022
Q2 		$417K Buy
+1,435
New +$417K 0.02% 428

Other funds holding XAGE

Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
AC
Antara Capital New York $30.2K AUM 5.24% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Mangrove Partners's XAGE Position: Q1 2023 in Review

Mangrove Partners sold out of Longevity Health Holdings, Inc. Common Stock (XAGE) in Q1 2023, closing a stake of 3,544 shares — an estimated $1.05M sold.

Mangrove Partners first reported a position in XAGE in Q2 2022 and held it in 3 quarters. The position peaked at $2.11M in Q3 2022. 40 funds tracked by Wall St. Rank hold XAGE as of Q1 2023.

  • Mangrove Partners reported no remaining Longevity Health Holdings, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Mangrove Partners sold 3,544 Longevity Health Holdings, Inc. Common Stock shares in Q1 2023, an estimated $1.05M.
  • Mangrove Partners first reported a position in Longevity Health Holdings, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
  • Mangrove Partners's Longevity Health Holdings, Inc. Common Stock position peaked at $2.11M in Q3 2022.
  • 40 funds tracked by Wall St. Rank held Longevity Health Holdings, Inc. Common Stock as of Q1 2023.

Based on Mangrove Partners's 13F filing for Q1 2023, filed 15 May 2023.